In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone

Imaging Dopamine Receptors in the Human Brain by Positron Tomography

1983 • 743 citations

Effects of Age on Dopamine and Serotonin Receptors Measured by Positron Tomography in the Living Human Brain

1984 • 701 citations

INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA

1978 • 513 citations

Receptor basis for dopaminergic supersensitivity in Parkinson's disease

1978 • 447 citations

Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects

1981 • 337 citations

Neurotransmitter receptor alterations in Parkinson's disease

1977 • 251 citations

[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy

1984 • 215 citations

Quantitative potentials of dynamic emission computed tomography.

1978 • 122 citations

Alterations in dopaminergic receptors in Huntington's disease

1977 • 89 citations

[11C]spiroperidol: synthesis, specific activity determination, and biodistribution in mice.

1982 • 76 citations

76Br-bromospiroperidol: A new tool for quantitative in-vivo imaging of neuroleptic receptors

1984 • 72 citations

Carrier-added and no-carrier-added syntheses of [18F]spiroperidol and [18F]haloperidol

1984 • 65 citations

QUANTITATIVE POTENTIALS OF DYNAMIC EMISSION COMPUTED TOMOGRAPHY

1979 • 51 citations

Characterization of specific binding of neuroleptic drugs in rat brain

1978 • 39 citations

HEADTOME III: A high quantitation and high resolution brain positron emission tomograph

1984 • 35 citations

Preparation and purification of ⁷⁷Br‐labelled p‐bromospiroperidol suitable for in vivo dopamine receptor studies

1983 • 32 citations

Synthesis and biological evaluation of p-bromospiperone as potential neuroleptic drug

1980 • 22 citations

Physical characterization of a time-of-flight positron emission tomography system for whole-body quantitative studies

1984 • 16 citations